Insider · CIK 0001237624

VOGELBAUM MARTIN

Reports to the SEC for 5 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001237624

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-04	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+301K sh	—	—	411,007
2024-06-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+390K sh	—	—	390,000
2023-06-01	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+64.7K sh	—	—	109,712
2023-06-01	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+89.9K sh	—	—	89,923
2022-09-14	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−10.8K sh	$10.28	−$111K	44,988
2022-06-02	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+23.8K sh	—	—	43,912
2022-06-02	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+11.9K sh	—	—	55,788
2022-06-02	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	33,993
2021-06-07	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−8,640 sh	$13.05	−$113K	20,160
2021-06-03	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+14.4K sh	—	—	28,800
2021-06-03	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.6K sh	—	—	21,600
2020-11-17	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−6,000 sh	$16.09	−$96.5K	14,400
2020-06-04	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+14.4K sh	—	—	20,400
2020-06-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.6K sh	—	—	21,600
2019-06-04	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-06-04	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-06-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2018-06-06	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2017-06-21	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-06-15	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-03-17	TVRDTvardi Therapeutics, Inc.P Purchase	Director	PPurchase	+248K sh	$4.93	+$1.22M	3,068,057
2016-03-16	TVRDTvardi Therapeutics, Inc.P Purchase	Director	PPurchase	+152K sh	$4.78	+$728K	2,820,330
2015-06-24	RCKTROCKET PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Director	AAward	+12K sh	$5.03	+$60.4K	21,857
2015-06-08	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2014-02-14	NephroGenex, Inc.C Conversion	Director	CConversion	+942K sh	—	—	942,455
2014-02-14	NephroGenex, Inc.C Conversion	Director	CConversion	+203K sh	—	—	1,145,829
2014-02-14	NephroGenex, Inc.A Award	Director	AAward	+181K sh	—	—	1,326,826
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director	CConversion	−5.63M sh	—	—	0
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director	CConversion	−494K sh	—	—	0
2014-02-14	NephroGenex, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	−1.22M sh	—	—	0
2014-02-14	NephroGenex, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	−107K sh	—	—	0
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director	CConversion	+1.22M sh	—	—	1,215,268
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director	CConversion	+107K sh	—	—	106,697
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director	CConversion	−1.22M sh	—	—	0
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director	CConversion	−107K sh	—	—	0
2014-02-05	TVRDTvardi Therapeutics, Inc.C Conversion	Director	CConversion	+2.44M sh	—	—	2,442,239
2014-02-05	TVRDTvardi Therapeutics, Inc.P Purchase	Director	PPurchase	+226K sh	$11.00	+$2.48M	2,668,057
2014-02-05	TVRDTvardi Therapeutics, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−6.11M sh	—	—	0
2014-01-30	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2009-06-23	MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2007-04-20	MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jun 64
VOGELBAUM MARTIN0001415889-24-015751
SEC(opens sec.gov)
Jun 54
VOGELBAUM MARTIN0001209191-23-034300
SEC(opens sec.gov)
Sep 164
VOGELBAUM MARTIN0001209191-22-050320
SEC(opens sec.gov)
Jun 64
VOGELBAUM MARTIN0001209191-22-034624
SEC(opens sec.gov)
Jun 74
VOGELBAUM MARTIN0001209191-21-038766
SEC(opens sec.gov)
Nov 194
VOGELBAUM MARTIN0001209191-20-059476
SEC(opens sec.gov)
Jun 84
VOGELBAUM MARTIN0001209191-20-035071
SEC(opens sec.gov)
Jul 14/A
VOGELBAUM MARTIN0001209191-19-039793
SEC(opens sec.gov)
Jun 64
VOGELBAUM MARTIN0001209191-19-035227
SEC(opens sec.gov)
Jun 84
VOGELBAUM MARTIN0001209191-18-036696
SEC(opens sec.gov)
Jun 234
Cara Therapeutics, Inc.0001209191-17-041753
SEC(opens sec.gov)
Jun 174
Cara Therapeutics, Inc.0001209191-16-128713
SEC(opens sec.gov)

Companies

Address

RHO CAPITAL PARTNERS 152 WEST 57TH STREET, 23RD FLOOR

NEW YORK, NY, 10019